Anti-CCR5/CXCR4 sheep monoclonal antibody - KS Biomedix Holdings

Drug Profile

Anti-CCR5/CXCR4 sheep monoclonal antibody - KS Biomedix Holdings

Alternative Names: Anti-CCR5/CXCR4; Anti-CCR5/CXCR4 MAb

Latest Information Update: 27 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator KS Biomedix Holdings; Nonindustrial source
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action CCR5 receptor antagonists; CXCR4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 27 Sep 2002 Discontinued - Preclinical for HIV-1 infections in France (unspecified route)
  • 27 Sep 2002 Discontinued - Preclinical for HIV-1 infections in United Kingdom (unspecified route)
  • 19 Oct 2000 Anti-CCR5/CXCR4 sheep monoclonal antibodies are available for licensing (http://www.ksbiomedix.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top